Cite Filings / ACAD / 0000102909-26-000519
Feed Companies Filings Check
Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

ACADIA PHARMACEUTICALS INC · Filed 2026-03-26 · Acc 0000102909-26-000519

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-03-26 4 EVP, CHIEF FINANCIAL OFFICER sold 7,385 shares at an average $21.55 ($159,136)
  • 2026-03-26 4 EVP, Head of Research & Dev sold 3,435 shares at $21.47 ($73,749)
  • 2026-03-26 4 Chief Executive Officer sold 11,641 shares at $21.47 ($249,932)
  • 2026-03-26 4 PRINCIPAL ACCOUNTING OFFICER sold 1,942 shares at an average $21.57 ($41,895)
  • 2026-03-26 4 EVP, CHIEF LEGAL OFFICER, SEC sold 3,844 shares at $21.47 ($82,531)
  • 2026-03-26 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…